| 2026-08-12 | 8-K | Form 8-K/A, Item 5.02 |
| 2026-08-06 | Press release | Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance · Q2 2026 |
| 2026-08-06 | 8-K | Form 8-K, Item 1.01 |
| 2026-07-29 | Press release | Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance |
| 2026-07-29 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-29 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-16 | Press release | Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States |
| 2026-07-09 | Press release | Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care |
| 2026-07-09 | Press release | Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate |
| 2026-07-06 | Press release | Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29 |
| 2026-07-01 | Press release | New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lowe |
| 2026-06-15 | Press release | Bausch + Lomb to Highlight Product Data at European Dry Eye Congress |
| 2026-06-10 | Press release | Bausch + Lomb to Showcase 14 Scientific Data Presentations at Optometry’s Meeting® 2026, Including an AOA Top Five Prese |
| Transcript | Earnings call transcript |
| 2026-06-01 | Press release | Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States |
| 2026-05-21 | Press release | Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference |
| 2026-05-20 | 8-K | Form 8-K, Item 5.07 |
| 2026-04-29 | Deck | Earnings presentation · Q1 2026 · Apr 2026 |
| 2026-04-29 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-29 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-10 | Proxy | Definitive proxy statement |
| 2026-03-20 | Deck | Investor presentation · Q1 2026 · Mar 2026 |
| 2026-02-18 | Deck | Investor presentation · Q4 2025 · Feb 2026 |
| 2026-02-18 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-18 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-01-12 | Deck | Investor presentation · Q4 2025 · Jan 2026 |
| 2026-01-02 | 8-K | Form 8-K, Item 1.01 |
| 2025-12-22 | 8-K | Form 8-K/A, Item 5.02 |
| 2025-12-17 | 8-K | Form 8-K, Item 5.02 |
| 2025-12-12 | 8-K | Form 8-K, Item 8.01 |
| 2025-11-13 | 8-K | Form 8-K, Item 7.01 |
| 2025-10-29 | 8-K | Form 8-K, Item 2.02 results |
| 2025-10-29 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-08-18 | 8-K | Form 8-K, Item 1.02 |
| 2025-07-30 | 8-K | Form 8-K, Item 2.02 results |
| 2025-07-30 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-07-23 | 8-K | Form 8-K, Item 5.02 |
| 2025-06-27 | 8-K | Form 8-K, Item 1.01 |
| 2025-06-18 | 8-K | Form 8-K, Item 8.01 |
| 2025-06-10 | 8-K | Form 8-K, Item 8.01 |